2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. - Wikidata - wikimedia - TriplyDB

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

http://www.wikidata.org/entity/Q46027527

about

Interval from loop electrosurgical excision procedure to pregnancy and pregnancy outcomes Cervical cancer screening: A never-ending developing program Current Cervical Carcinoma Screening Guidelines Major clinical research advances in gynecologic cancer in 2014 Natural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literature Major clinical research advances in gynecologic cancer in 2015 E6/E7 mRNA testing for human papilloma virus-induced high-grade cervical intraepithelial disease (CIN2/CIN3): a promising perspective Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic review.Population-based screening for cancer: hope and hype.Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance Program.Deciphering the Multifactorial Susceptibility of Mucosal Junction Cells to HPV Infection and Related Carcinogenesis.Comments on the Publication of Munich Nomenclature III by the Cytology Coordination Conference Pooled analysis on the necessity of random 4-quadrant cervical biopsies and endocervical curettage in women with positive screening but negative colposcopy A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women Intent to participate in future cervical cancer screenings is lower when satisfaction with the decision to be vaccinated is neutral.Kissing and hpv: honest popular visions, the human papilloma virus, and cancers Interdisciplinary Treatment for Cutaneous Abdominal Wall Metastasis from Cervical Cancer with Resection and Reconstruction of the Abdominal Wall Using Free Latissimus Dorsi Muscle Flap: A Case Report.Treatment of cervical precancers: back to basics.Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis.Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women The clinical performance of APTIMA human papillomavirus and Hybrid Capture 2 assays in the triage of lesser abnormal cervical cytologies Cervical human papillomavirus testing to triage borderline abnormal pap tests in HIV-coinfected women.Cytologic surveillance versus immediate colposcopy for women with a cervical smear diagnosis of low-grade squamous intraepithelial lesion in a poor setting in Nigeria.Atypical endometrial cells and atypical glandular cells favor endometrial origin in Papanicolaou cervicovaginal tests: Correlation with histologic follow-up and abnormal clinical presentations.Patient concerns about human papillomavirus testing and 5-year intervals in routine cervical cancer screening.Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.Overview of the CDC Cervical Cancer (Cx3) Study: an educational intervention of HPV testing for cervical cancer screening A novel use of a statewide telecolposcopy network for recruitment of participants in a Phase I clinical trial of a human papillomavirus therapeutic vaccine Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.Evidence supporting see-and-treat management of cervical intraepithelial neoplasia: a systematic review and meta-analysis.Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis.The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women.Communication practices about HPV testing among providers in Federally Qualified Health Centers.The incidence of human papillomavirus infection following treatment for cervical neoplasia: a systematic review.A study of HPV typing for the management of HPV-positive ASC-US cervical cytologic results.The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.Improving compliance with cervical cancer screening guidelines.Cost-effectiveness analysis of anal cancer screening in women with cervical neoplasia in British Columbia, Canada.Predictive value of p16/Ki-67 immunocytochemistry for triage of women with abnormal Papanicolaou test in cervical cancer screening: a systematic review and meta-analysis.

P2860

Q24611082-61B7750A-0C3A-4FFF-AF4B-F431E67BE266 Q26798416-5BD5E563-0B93-4CA4-889B-E1439EB71F6D Q26799522-411958BA-51C1-4B39-8ED1-F2042202A6D9 Q26992183-43ADD5AB-3424-4803-B533-60F2A9CAD1E3 Q28072648-4B9F1EF7-0F85-43BA-A5E6-F691BD3F58D5 Q28077183-2E193417-D572-44E0-A717-7546CB341C2D Q28087374-6DEAC53D-A837-4678-98A7-00CD4C8F9913 Q28392615-34463093-54BD-42AB-B944-40A2449E657B Q30238779-8979A74A-184F-4C87-A611-B0988B6F2F61 Q30251601-E7A5D3F6-B82B-4C95-B991-CC601D0FCFFD Q30354591-B273AB7B-B046-4297-A968-3E3EC8418159 Q33613540-D0BB2A0F-022B-4FC2-B3A9-A6D879C329B3 Q33626144-6D48963D-379B-4A1B-AEFC-E78E3C8E3CBC Q33627102-B9F91795-C227-4A38-84A2-50AF85A38AA8 Q33679663-80D99A3E-5D5E-4E8D-A55F-0B20AA07A2F3 Q33734307-B86B91E5-45B6-46BD-9F66-E878C772F9DB Q33763951-5401F4CC-BCEE-496F-9E5C-E3CC9096D2F9 Q33800961-7CAD4C1D-8543-4FB7-BDED-C04323314889 Q33830948-BFDCC84B-F740-4A63-AD10-76A694631B67 Q33961062-6B9EAE3A-17D6-4523-8C05-130393688CDC Q34216900-AB9AD731-414B-49AB-B2B0-31A940511356 Q34330297-6475B276-30B3-4EBD-B8A3-4406C8FE7BEC Q34337277-14251623-9CA0-460E-8863-C58539A6D932 Q34609662-C4F09088-A8F2-4A8D-98E2-BFD9264320EE Q34617400-8959DDFF-6092-49AF-9790-2181B4958BA0 Q35007699-75B26B9D-6714-4463-BAE3-7D06A2D20016 Q35282164-E346A33C-4BE1-46C7-881F-E6A9AA90E8D9 Q35282197-2CB6E417-7DFE-423C-8F4F-6CE3586E24F9 Q35582343-696EF39D-0A69-4AF3-99A0-11CD76F7E9DF Q35605623-9845FCF2-36A0-4F58-8F65-E859F72B25FD Q35692803-98A04942-5149-4433-B5F9-D28DBEA189D8 Q35805474-F12E15F4-3A76-4A18-A55A-9C3F0C8C2256 Q35809257-1579329F-99D1-4D96-9029-2B10E6767BAE Q35880460-9DB2A8A2-4F8A-41F3-BDEA-11CC8A66C075 Q35984769-98C6BCE4-7B11-48C5-A32B-159758B4E7FF Q36016617-A02C2641-7CAF-4CAD-98EE-499ECEE0B2A0 Q36029632-68BD7E32-8C85-49D2-9BE9-98559F75DB72 Q36058295-4D70518A-C45B-4123-9EB8-FAB3DC70F125 Q36062717-FD1581D8-28FE-49FE-BFDE-8C8274A6D572 Q36091529-A7C7CC7E-CC97-4220-A1AA-D01C8760636E

P2860

2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.

http://www.wikidata.org/entity/Q46027527

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

2012 updated consensus guideli ...... g tests and cancer precursors.

@en

2012 updated consensus guideli ...... g tests and cancer precursors.

@nl

type

label

2012 updated consensus guideli ...... g tests and cancer precursors.

@en

2012 updated consensus guideli ...... g tests and cancer precursors.

@nl

prefLabel

2012 updated consensus guideli ...... g tests and cancer precursors.

@en

2012 updated consensus guideli ...... g tests and cancer precursors.

@nl

P1433

Q46027527-09A116B9-AA0E-44A2-9714-4E5B99820266

P1476

Q46027527-B27B00B3-9176-4291-9BFA-0EBCD69CEE90

P2093

Q46027527-3A1C7631-E0CB-4310-A7AD-FDAE59D70C98

Q46027527-447397A3-A759-40A6-876F-0065E401A064

Q46027527-6549EC66-AA5B-4E38-97B9-1BE150AA7F7D

Q46027527-6C294E97-8DFD-41B2-A3BF-91127F12880F

Q46027527-7C1838BE-17D3-437C-B75C-620360DABE69

Q46027527-E344BF24-80BF-4890-8211-4FC3F98211FD

Q46027527-E3FC7320-7A99-4490-AE05-E0A4C8F6D7D0

Q46027527-E627B1F9-AD3F-4862-8039-083E6106C3D3

P304

Q46027527-6E380491-2311-43F8-AB53-26D767BA3D26

P31

Q46027527-0BD0D604-92C6-49B8-BCE5-C327F7F40CF8

P356

Q46027527-82A34D3F-6B66-46D7-930F-DFA1C594F7F4

P407

Q46027527-DED2D44A-4596-4877-A153-EE05507EC54B

P433

Q46027527-A6A58E6B-8649-43A2-B2F4-97F13808D345

P478

Q46027527-3CFD0783-385D-45DF-B490-B407F9B334A8

P50

Q46027527-CB481935-EE33-4C44-AA3A-CBA5B36DA95E

Q46027527-E538050A-7440-4CA1-B530-4AA69608D483

P577

Q46027527-59BDD8E1-953C-4376-8F75-BE0E06E81BFF

P698

Q46027527-5A3A2519-9F05-4A1A-91E9-3B605246F6B7

P356

AOG.0B013E3182883A34

P1433

Obstetrics and Gynecology

P1476

2012 updated consensus guideli ...... g tests and cancer precursors.

@en

P2093

2012 ASCCP Consensus Guidelines Conference

http://www.w3.org/2001/XMLSchema#string

Diane Solomon

http://www.w3.org/2001/XMLSchema#string

Herschel W Lawson

http://www.w3.org/2001/XMLSchema#string

Hormuzd A Katki

http://www.w3.org/2001/XMLSchema#string

L Stewart Massad

http://www.w3.org/2001/XMLSchema#string

Mark H Einstein

http://www.w3.org/2001/XMLSchema#string

Walter K Kinney

http://www.w3.org/2001/XMLSchema#string

Warner K Huh

http://www.w3.org/2001/XMLSchema#string

P304

829-846

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/AOG.0B013E3182883A34

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Wentzensen

P577

2013-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23635684

http://www.w3.org/2001/XMLSchema#string